Which of the following factors markedly increases the risk of valproate-induced liver toxicity?
## **Core Concept**
Valproate-induced liver toxicity, also known as hepatotoxicity, is a rare but serious side effect of valproate therapy. This condition is more likely to occur in certain individuals with specific risk factors. The underlying principle involves the metabolism of valproate and the individual's susceptibility to its toxic metabolites.
## **Why the Correct Answer is Right**
The correct answer, **D. Young age (< 2 years) and concomitant use of other antiepileptic drugs**, is right because young children under 2 years of age are at a higher risk of developing valproate-induced hepatotoxicity, especially when valproate is used in combination with other antiepileptic drugs. This increased risk is attributed to the immaturity of the liver in young children and the potential for drug interactions that may enhance the formation of toxic metabolites.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain genetic mutations can affect drug metabolism, the specific association with valproate-induced liver toxicity is more strongly linked to young age and polypharmacy rather than a broad category of genetic predispositions.
- **Option B:** Although liver disease can increase the risk of drug-induced hepatotoxicity in general, valproate-induced liver toxicity is not specifically highlighted as being more common in patients with pre-existing liver disease compared to the risk associated with young age and concomitant antiepileptic drug use.
- **Option C:** This option does not provide a commonly recognized risk factor for valproate-induced liver toxicity.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients under 2 years of age, especially those with mitochondrial disorders or who are on multiple antiepileptic drugs, should be closely monitored for signs of liver toxicity when started on valproate. Early detection of liver enzymes elevation can help prevent severe hepatotoxicity.
## **Correct Answer:** D. Young age (< 2 years) and concomitant use of other antiepileptic drugs.